Metabolism of Innate Immune Cells in Cancer

by Ronan Talty, Kelly Olino
Published 2021-02-01

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma

by Nicholas D. Klemen, Melinda Wang, Kelly Olino, James Clune, Stephan Ariyan, Sarah A. Weiss, Charles Cha, Jill C. Rubinstein
Published 2020-06-01

Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.

by Lei Zheng, Kelly Foley, Lanqing Huang, Ashley Leubner, Guanglan Mo, Kelly Olino, Barish H Edil, Masamichi Mizuma, Rajni Sharma, Dung T Le, Robert A Anders, Peter B Illei, Jennifer E Van Eyk, Anirban Maitra, Daniel Laheru, Elizabeth M Jaffee
Published 2011-04-01

Neoadjuvant anti–programmed cell death 1 therapy for locally advanced basal cell carcinoma in treatment-naive patients: A case series

by Katherine Given Ligtenberg, MD, PhD, MBA, Jamie Katy Hu, BA, William Damsky, MD, PhD, Kelly Olino, MD, Harriet Kluger, MD, James Clune, MD, Shawn E. Cowper, MD, Gauri Panse, MD, Jonathan Leventhal, MD, Sarah A. Weiss, MD
Published 2020-07-01

Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma

by Nicholas D. Klemen, Melinda Wang, Paul L. Feingold, Kirsten Cooper, Sabrina N. Pavri, Dale Han, Frank C. Detterbeck, Daniel J. Boffa, Sajid A. Khan, Kelly Olino, James Clune, Stephan Ariyan, Ronald R. Salem, Sarah A. Weiss, Harriet M. Kluger, Mario Sznol, Charles Cha
Published 2019-07-01